Nitrazepam Accord (Nitrazepam)

Nitrazepam binds to a specific site on the GABA‑A receptor complex, enhancing the inhibitory action of the neurotransmitter GABA. This increases chloride ion influx, hyperpolarizes neurons, and reduces neuronal excitability, producing sedative, anxiolytic, and anticonvulsant effects.

The appropriate dose of Nitrazepam Accord is determined by the prescribing clinician based on the patient’s condition, age, response, and any relevant medical factors. Dosage instructions are provided on the prescription label.

Safety of nitrazepam in pregnancy or lactation has not been definitively established. It should only be used when the potential benefit justifies the potential risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To request Nitrazepam Accord, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nitrazepam shares the core mechanism of GABA‑A modulation with other benzodiazepines but has a relatively long half‑life, which can provide sustained therapeutic effect for insomnia or seizure control. Compared with shorter‑acting agents, it may have a higher risk of residual daytime sedation.

Nitrazepam Accord should be stored at ambient temperature, below 25 °C, in its original packaging. Protect the product from moisture, direct sunlight, and excessive heat to maintain potency and stability.

Nitrazepam Accord is taken orally, usually with a glass of water. The exact timing (e.g., before bedtime for insomnia) and whether it should be taken with food are determined by the prescribing clinician.

Serious risks include respiratory depression, severe allergic reactions such as anaphylaxis, dependence and withdrawal syndrome, and rare paradoxical reactions like agitation or aggression. Patients should be monitored closely for any of these events.

Nitrazepam Accord is contraindicated in patients with known hypersensitivity to nitrazepam or other benzodiazepines, those with severe respiratory insufficiency, and individuals who are currently abusing alcohol or other central nervous system depressants.